Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to see how well patients in an early phase of their
illness respond to treatment and whether this depends on how well they functioned socially,
academically and vocationally before becoming ill. The study also examines whether patients
with more insight into their illness have better outcomes.